Skip to main content
SpringerLink
Log in

Brain Regional Pharmacokinetics of 11C-Labeled Diphenylhydantoin and Pimozide in Man

  • Chapter
Positron Emission Tomography of the Brain

Abstract

Positron emission tomography (PET) offers the new opportunity to study, in vivo and non-invasively, the brain regional pharmacokinetics of labeled drugs in man.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Alvin JD, Bush MT (1977) Diphenylhydantoins and other hydantoins In: Vida JA (ed) Anticonvulsivants Academic, New York p 116

    Google Scholar 

  2. Baron JC, Bousser MG, Comar D, Soussaline F, Castaigne P (1981) Non-invasive tomographic study of cerebral blood flow and oxygen metabolism in vivo: potentials, limitations and clinical applications in cerebral ischemic disorders. Eur Neurol 20: 273–284

    Article  PubMed  CAS  Google Scholar 

  3. Firemark H, Barlow CF, Roth LJ (1963) The entry accumulation and binding of diphenylhydantoin-2-C14 in brain–studies on adult, immature and hypercapnic cats. Int J Neuropharmacol 2: 25–38

    Article  CAS  Google Scholar 

  4. Goldberg MA, Crandall PH (1978) Human brain binding of phenytoin Neurology 28: 881–885

    CAS  Google Scholar 

  5. Harvey CD, Sherwin AL, Van der Kleyn E (1977) Distribution of anticonvulsivant drugs in gray and white matter of human brain. Can J Neurol Sci 4: 89–92

    PubMed  CAS  Google Scholar 

  6. Houghton GW, Richens A, Toseland PA et al. (1975) Brain concentration of phenytoin, phenobarbitone and primidone in epileptic patients. Eur J Clin Pharmacol 9: 73–78

    Article  PubMed  CAS  Google Scholar 

  7. Kutt H, Louis S, McDowell F (1968) Intravenous diphenylhydantoin in experimental seizures. Arch Neurol 18: 465–471

    Article  PubMed  CAS  Google Scholar 

  8. Munari C, Talairach J, Rovei V et al. (1980) Brain levels of antiepileptic drugs in man. Epilepsy: a clinical and experimental research. Monogr Neural Sci 5: 213–220

    PubMed  CAS  Google Scholar 

  9. Ramsay RE, Hammond EJ, Perchalsky RJ et al. (1979) Brain uptake of phenytoin phenobarbital and diazepam. Arch Neurol 36: 535–539

    Article  PubMed  CAS  Google Scholar 

  10. Rapport RL, Harris AB, Fried PN et al. (1975) Human epileptic brain. Na, K, ATP-ase activity and phenytoin concentrations. Arch Neurol 32: 549–554

    Google Scholar 

  11. Roeda D, Westera G (1981) The synthesis of some 11C-labelled antiepileptic drugs with potential utility as radiopharmaceuticals: hydantoins and barbiturate. Int J Appl Radiat Isot 32: 843–845

    Article  PubMed  CAS  Google Scholar 

  12. Sherwin AL, Eisen AA, Sokolowski CD (1973) Anticonvulsant drugs in human epileptogenic brain. Correlation of phenobarbital and diphenylhydantoin levels with plasma. Arch Neurol 29: 73–77

    Google Scholar 

  13. Sironi VA, Gabrini G, Porro MG et al. (1980) Antiepileptic drug distribution in cerebral cortex, Ammon’s horn, and amygdala in man. J Neurosurg 52: 686–692

    Google Scholar 

  14. Stavchansky SA, Tilbury RS, McDonald JM et al. (1978) In vivo distribution of carbon-11 phenytoin and its major metabolite and their use in scintigraphic imaging. J Nucl Med 19: 936–941

    PubMed  CAS  Google Scholar 

  15. Vajda F, Williams FM, Davidson S et al. (1974) Human brain, cerebrospinal fluid and plasma concentrations of diphenylhydantoin and phenobarbital. Clin Pharmacol Ther 15: 597–603

    PubMed  CAS  Google Scholar 

  16. Wilder BJ, Ramsay RE, Willmore U et al. (1977) Efficacy of intravenous phynytoin in the treatment of status epilepticus: kinetics of central nervous system penetration. Ann Neurol 1: 511–518

    Article  PubMed  CAS  Google Scholar 

  17. Winstead MB, Parr SJ, Royal MJ (1976) Relationship of molecular structure to in vivo scintigraphic distribution patterns of carbon-11 labeled compounds -3-(11C) hydantoins. J Med Chem 19: 279–286

    Article  PubMed  CAS  Google Scholar 

  18. Baudry M, Martres MP, Schwartz JC (1977) In vivo binding of 3H-pimozide in mouse striatum. Effects of dopamine agonists and antagonists. Life Sci 21: 1163–1170

    Google Scholar 

  19. Berger B, Thierry AM, Tassin JP, Moyne MA (1976) Dopaminergic innervation of the rat prefrontal cortex: a fluorescence histochemical study. Brain Res 106: 133–145

    Article  PubMed  CAS  Google Scholar 

  20. Comar D, Mazière M, Godot JM, Berger G, Soussaline F, Menini C, Arfel G, Naquet R (1979) Visualisation of 11C-flunitrazepam displacement in the brain of the live baboon. Nature 280: 329–331

    Article  PubMed  CAS  Google Scholar 

  21. Comar D, Mazière MA, Cepeda C, Godot JM, Menini C, Naquet R (1981) The kinetics and displacement of 11C-flunitrazepam in the brain of the living baboon. Eur J Pharmacol 75: 21–26

    Article  PubMed  CAS  Google Scholar 

  22. Crouzel C, Mestelan G, Kraus E, Lecomte JM, Comar D (1980) Synthesis of a 11C-labelled neuroleptic drug: pimozide. Int J Appl Radiat Isot 31: 545–548

    Article  PubMed  CAS  Google Scholar 

  23. Janssen PM, Allewijn FTN (1968) Pimozide, a clinically novel, highly potent and orally long-act-J. C. Baron et al.: Brain Regional Pharmacokineticsing neuroleptic drug. II. Kinetic study of the distribution of pimozide and metabolites in brain, liver, and blood of the Wistar rat. Arzneim Forsch 18: 282–287

    Google Scholar 

  24. Laduron PM (1980) Dopamine and muscarinic receptors: in vivo identification, axonal transport and solubilization. In: Yamamura, Olsen, Usdin (eds) Psychopharmacology and biochemistry of neurotransmitter receptors. Elsevier, Amsterdam pp 115–132

    Google Scholar 

  25. Laduron PM, Jansen PFM, Leysen JE (1978) Spiperone, a ligand of choice for neuroleptic receptors. 2. Regional distribution and in vivo displacement by neuroleptic drugs. Biochem Pharmacol 27: 371–321

    Google Scholar 

  26. Leysen JE (to be published) Receptors for neuroleptic drugs. In: Burrows GD, Weney JS (eds) Advances in human psychopharmacology, vol 3. JAI Press, Greenwich

    Google Scholar 

  27. Leysen JE, Gommeren W (1978) Different kinetic properties of neuroleptic receptor binding in the rat striatum and frontal cortex. Life Sci 23: 447–452

    Article  PubMed  CAS  Google Scholar 

  28. Mac Culloch JM, Harper AM (1977) Cerebral circulation: effect of stimulation and blockade of dopamine receptors. Am J Physiol 233: H 222-H 227

    Google Scholar 

  29. Mazière M, Comar D, Godot JM, Collard P, Cepeda C, Naquet R (1981) In vivo characterization of myocardium muscarinic receptors by positron emission tomography. Life Sci 29: 2391–2397

    Article  PubMed  Google Scholar 

  30. Maxiotta JC, Phelps ME, Plummer D, Kuhl DE (1981) Quantitation in positron emission computed tomography: 5. Physicalanatomical effects. J Comput Assist Tomog 5: 734–743

    Google Scholar 

  31. Murrin LC (1981) Neurotransmitter receptors, neuroanatomical localization through autoradiography. Int Rev Neurobiol 22: 111–171

    Article  PubMed  CAS  Google Scholar 

  32. Owen F, Cross AJ, Waddington JL, Poulter M, Gamble SJ, Crow TJ (1980) Dopamine-mediated behaviour and 3H-spiperone binding to striatal membranes in rats after nine months haloperidol administration. Life Sci 26: 55–59

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. J. C. Baron
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. D. Comar
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. C. Crouzel
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. D. Roeda
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. G. Mestelan
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. E. Zarifian
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. C. Munari
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. C. Stoffels
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. J. Bancaud
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. J. P. Chodkiewicz
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. H. Loo
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Y. Agid
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Max-Planck-Institut für Neurologische Forschung und Neurologische, Klinik des Krankenhauses Merheim, Ostmerheimer Straße 200, D-5000, Köln 91, Germany

    Wolf-Dieter Heiss

  2. Division of Biophysics, Department of Radiological Sciences and Laboratory of Nuclear Medicine, University of California, 90024, Los Angeles, California, USA

    Michael E. Phelps

Rights and permissions

Reprints and permissions

Copyright information

© 1983 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Baron, J.C. et al. (1983). Brain Regional Pharmacokinetics of 11C-Labeled Diphenylhydantoin and Pimozide in Man. In: Heiss, WD., Phelps, M.E. (eds) Positron Emission Tomography of the Brain. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-95428-3_26

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-95428-3_26

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-12130-5

  • Online ISBN: 978-3-642-95428-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation